Rouse BT - Search Results

1

Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognize virus nonstructural proteins.

Martin S, Courtney RJ, Fowler G, Rouse BT. Martin S, et al. Among authors: rouse bt. J Virol. 1988 Jul;62(7):2265-73. doi: 10.1128/JVI.62.7.2265-2273.1988. J Virol. 1988. PMID: 2836610 Free PMC article.

2

Murine cytotoxic T lymphocytes specific for herpes simplex virus type 1 recognize the immediate early protein ICP4 but not ICP0.

Martin S, Zhu XX, Silverstein SJ, Courtney RJ, Yao F, Jenkins FJ, Rouse BT. Martin S, et al. Among authors: rouse bt. J Gen Virol. 1990 Oct;71 ( Pt 10):2391-9. doi: 10.1099/0022-1317-71-10-2391. J Gen Virol. 1990. PMID: 2172452

3

Antiviral cytotoxic T lymphocyte induction and vaccination.

Rouse BT, Norley S, Martin S. Rouse BT, et al. Rev Infect Dis. 1988 Jan-Feb;10(1):16-33. doi: 10.1093/clinids/10.1.16. Rev Infect Dis. 1988. PMID: 2451265 Review.

4

Herpes simplex virus-induced stromal keratitis: role of T-lymphocyte subsets in immunopathology.

Newell CK, Martin S, Sendele D, Mercadal CM, Rouse BT. Newell CK, et al. Among authors: rouse bt. J Virol. 1989 Feb;63(2):769-75. doi: 10.1128/JVI.63.2.769-775.1989. J Virol. 1989. PMID: 2536102 Free PMC article.

5

Evaluation of antiviral immunity using vaccinia virus recombinants expressing cloned genes for herpes simplex virus type 1 glycoproteins.

Martin S, Cantin E, Rouse BT. Martin S, et al. Among authors: rouse bt. J Gen Virol. 1989 Jun;70 ( Pt 6):1359-70. doi: 10.1099/0022-1317-70-6-1359. J Gen Virol. 1989. PMID: 2543783

6

Recombinant vaccinia virus expressing the herpes simplex virus type 1 glycoprotein C protects mice against herpes simplex virus challenge.

Weir JP, Bennett M, Allen EM, Elkins KL, Martin S, Rouse BT. Weir JP, et al. Among authors: rouse bt. J Gen Virol. 1989 Oct;70 ( Pt 10):2587-94. doi: 10.1099/0022-1317-70-10-2587. J Gen Virol. 1989. PMID: 2794972

7

Cytotoxic T lymphocytes. Their relevance in herpesvirus infections.

Martin S, Cantin E, Rouse BT. Martin S, et al. Among authors: rouse bt. Ann N Y Acad Sci. 1988;532:257-72. doi: 10.1111/j.1749-6632.1988.tb36344.x. Ann N Y Acad Sci. 1988. PMID: 2845846

8

Mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: cytotoxic T cells.

Martin S, Moss B, Berman PW, Laskey LA, Rouse BT. Martin S, et al. Among authors: rouse bt. J Virol. 1987 Mar;61(3):726-34. doi: 10.1128/JVI.61.3.726-734.1987. J Virol. 1987. PMID: 3027400 Free PMC article.

9

Production, binding characteristics, and immunogenicity of heterologous anti-idiotypic antibody to herpes simplex virus glycoprotein C.

Lathey JL, Courtney RJ, Rouse BT. Lathey JL, et al. Among authors: rouse bt. Viral Immunol. 1987 Spring;1(1):13-23. doi: 10.1089/vim.1987.1.13. Viral Immunol. 1987. PMID: 3509672

10

Apparent requirement for CD4+ T cells in primary anti-herpes simplex virus cytotoxic T-lymphocyte induction can be overcome by optimal antigen presentation.

Mercadal CM, Martin S, Rouse BT. Mercadal CM, et al. Among authors: rouse bt. Viral Immunol. 1991 Fall;4(3):177-86. doi: 10.1089/vim.1991.4.177. Viral Immunol. 1991. PMID: 1687350

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

407 results

Search Page

Filters